Benchmark Maintains Speculative Buy on Genelux, Lowers Price Target to $20
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Benchmark analyst Bruce D. Jackson maintains Genelux (NASDAQ:GNLX) with a Speculative Buy and lowers the price target from $23 to $20.
Benchmark analyst Bruce D. Jackson maintains Genelux (NASDAQ:GNLX) with a Speculative Buy and lowers the price target from $23 to $20.